Johnson & Johnson Stock News

The government has received a donation of 1.17 million doses of Johnson and Johnson vaccines from the United States government. The consignment now brings to over five million the number of donations from the US government. The government is also expecting another consignment of one million doses of the Pfizer vaccine pushing the US donations to [] The post Kenya Receives 1.17 Million Covid-19 Doses appeared first on Uzalendo News .

Related Stocks: TKTT , RUI , 9934 , 09988 , 09888 , 00700 , FMC , NOEJ , RHM , GOOG , JNJ , NOVN , BOL , BABA , BIDU , STAN , BAB ,

Updated on December 10th, 2021 by Felix Martinez Companies that have at least 50 years of dividend growth are considered Dividend Kings. Dividend growth investors wont be surprised to find large cap names like Johnson & Johnson (JNJ) and 3M (MMM) among the Dividend Kings. These large cap names are some of the most widely [] The post Dividend Kings In Focus: SJW Group appeared first on Sure Dividend .

Howland Capital Management LLC grew its stake in Johnson & Johnson (NYSE:JNJ) by 0.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 144,601 shares of the company’s stock after buying an additional 245 shares during the period. Johnson & Johnson accounts […]

Harel Insurance Investments & Financial Services Ltd. raised its stake in Johnson & Johnson (NYSE:JNJ) by 350.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 43,053 shares of the company’s stock after buying an additional 33,488 shares during the period. Harel Insurance Investments […]

Cerity Partners LLC lowered its position in shares of Johnson & Johnson (NYSE:JNJ) by 1.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 241,978 shares of the company’s stock after selling 3,848 shares during the quarter. Johnson & Johnson makes up approximately […]

MBE Wealth Management LLC raised its stake in Johnson & Johnson (NYSE:JNJ) by 14.3% during the 3rd quarter, HoldingsChannel reports. The firm owned 1,418 shares of the company’s stock after acquiring an additional 177 shares during the period. MBE Wealth Management LLC’s holdings in Johnson & Johnson were worth $229,000 as of its most recent […]

New York State Teachers Retirement System lessened its stake in shares of Johnson & Johnson (NYSE:JNJ) by 3.8% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,120,198 shares of the companys stock after selling 122,419 shares during the quarter. Johnson []

The company recently announced that it would be splitting into two separate, publicly traded entities.

The health ministry on Friday announced that the vaccination portal has opened for the booking of Johnson & Johnson booster shots. Up until now, people could only get a booster at walk-in vaccination centres. People who were originally vaccinated with the Janssen (Johnson & Johnson) vaccine can choose between the

The usage of routinely used medications like hydroxychloroquine to treat COVID-19 has seen a remarkable increase in demand. Owing to the demand for these treatments, manufacturers of COVID-19 management drugs have a lot of prospects, as many wealthy countries are

Monument Capital Management boosted its holdings in Johnson & Johnson (NYSE:JNJ) by 14.7% in the third quarter, HoldingsChannel reports. The firm owned 3,251 shares of the companys stock after purchasing an additional 416 shares during the period. Monument Capital Managements holdings in Johnson & Johnson were worth $525,000 at the end of the most recent []

The Cancer Genome Projects'' goal is to classify sequence variants and changes critical in the growth of human cancers. The project involves the systematic screening of coding genes and flanking splice junctions of all genes in the human genome for

The Psoriasis Treatment Market covers the present scenario (with the base year being 2021) and the growth prospects of global Psoriasis Treatment market for 20212028. The report discusses the key drivers influencing market growth, opportunities, the challenges and the risks